Recombinant SARS-CoV-2 Nucleocapsid Protein for Diagnostic Testing
The new recombinant SARS-CoV-2 nucleocapsid protein is for covid-19 diagnostic test manufacturers, vaccine developers, and researchers globally.
Read MorePosted by | Apr 20, 2020 | Biochemicals & Chemical Reagents, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The new recombinant SARS-CoV-2 nucleocapsid protein is for covid-19 diagnostic test manufacturers, vaccine developers, and researchers globally.
Read MorePosted by | Apr 20, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The Veros SARS-CoV-2 assay is a simple disposable test for covid-19 that uses a nasal swab sample to give a result in less than 10 minutes, without the need for any instrumentation.
Read MorePosted by | Apr 20, 2020 | Covid 19, Information Technology |
The surveillance service identifies infectious disease warning signs, including increased temperature, high respiratory rate, cough, and shortness of breath.
Read MorePosted by | Apr 16, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The new saliva collection method will allow for broader population screening for covid-19 than the current method of nose and throat swabs.
Read MorePosted by | Apr 15, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Based on CDC guidelines, the guidance will help ensure infection control in a variety of patient settings.
Read More